大麦水孔蛋白基因HvTIP2;1及其启动子的表达特性分析

组织特异性启动子作为基因工程的一种重要调控元件,在生物反应器、转基因新品种培育等领域有重要的应用前景。基于芯片数据的基因数字化差异显示分析,筛选到一个根特异表达的大麦水孔蛋白基因Hv TIP2;1,利用实时荧光定量RT-PCR方法了解该基因在不同组织和处理条件下的表达特性,并对基因启动子及功能进行了研究。结果表明,Hv TIP2;1表达具有根特异性并受植物生长发育的调控,其在成株期的表达量明显高于苗期。ABA激素处理组,Hv TIP2;1表现先上升,处理10h后又下降的表达变化趋势;铝、锰有毒金属离子处理组,Hv TIP2;1表达量明显高于对照组,但表现出上升-下降-上升的波动变化特征;盐胁迫导致Hv TIP2;1表达量持续下降,而干旱诱导Hv TIP2;1表达量不断升高,处理24h后表达量迅速下降,低于对照水平。利用PCR方法克隆位于基因编码区上游的启动子序列Hv1310p,该序列含有多个与根特异表达和胁迫响应有关的顺式作用元件。通过5'端缺失法分别构建514bp和1 258bp启动子的融合GUS报告基因表达载体,转基因烟草的GUS活性检测表明两个启动子片段都具有根特异性的启动活性。     

Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance

Glioma contains abundant hypoxic regions which provide niches to promote the maintenance and expansion of glioma stem cells (GSCs), which are resistant to conventional therapies and responsible for recurrence. Given the fact that miR-210 plays a vital role in cellular adaption to hypoxia and in stem cell survival and stemness maintenance, strategies correcting the aberrantly expressed miR-210 might open up a new therapeutic avenue to hypoxia GSCs. In the present study, to explore the possibility of miR-210 as an effective therapeutic target to hypoxic GSCs, we employed a lentiviral-mediated anti-sense miR-210 gene transfer technique to knockdown miR-210 expression and analyze phenotypic changes in hypoxic U87s and SHG44s cells. We found that hypoxia led to an increased HIF-2α mRNA expression and miR-210 expression in GSCs. Knockdown of miR-210 decreased neurosphere formation capacity, stem cell marker expression and cell viability, and induced differentiation and G0/G1 arrest in hypoxic GSCs by partially rescued Myc antagonist (MNT) protein expression. Knockdown of MNT could reverse the gene expression changes and the growth inhibition resulting from knockdown of miR-210 in hypoxic GSCs. Moreover, knockdown of miR-210 led to increased apoptotic rate and Caspase-3/7 activity and decreased invasive capacity, reactive oxygen species (ROS) and lactate production and radioresistance in hypoxic GSCs. These findings suggest that miR-210 might be a potential therapeutic target to eliminate GSCs located in hypoxic niches.     

Hypoxic preconditioning reinforces cellular functions of autologous peripheral blood-derived cells in rabbit hindlimb ischemia model

Peripheral blood mononuclear cell (PBMNC) is one of powerful tools for therapeutic angiogenesis in hindlimb ischemia. However, traditional approaches with transplanted PBMNCs show poor therapeutic effects in severe ischemia patients. In this study, we used autograft models to determine whether hypoxic pretreatment effectively enhances the cellular functions of PBMNCs and improves hindlimb ischemia. Rabbit PBMNCs were cultured in the hypoxic condition. After pretreatment, cell adhesion, stress resistance, and expression of angiogenic factor were evaluated in vitro. To examine in vivo effects, we autografted preconditioned PBMNCs into a rabbit hindlimb ischemia model on postoperative day (POD) 7. Preconditioned PBMNCs displayed significantly enhanced functional capacities in resistance to oxidative stress, cell viability, and production of vascular endothelial growth factor. In addition, autologous transplantation of preconditioned PBMNCs significantly induced new vessels and improved limb blood flow. Importantly, preconditioned PBMNCs can accelerate vessel formation despite transplantation on POD 7, whereas untreated PBMNCs showed poor vascularization. Our study demonstrated that hypoxic preconditioning of PBMNCs is a feasible approach for increasing the retention of transplanted cells and enhancing therapeutic angiogenesis in ischemic tissue.